Webinar live date: Wednesday 5 December 2018 07:00 [PST] 10:00 [EST] 15:00 [GMT]. Learn how a standardized approach for the bioanalysis of biotherapeutics by hybrid LC–MS is applied in a contract research environment, whilst also considering compliance with regulatory requirements.
Webinar live date: Wednesday 14 November 2018 07:00 [PST] 10:00 [EST] 15:00 [GMT]. Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant?
Webinar live date: Thursday 29 November 07:00 [PST] 10:00 [EST] 15:00 [GMT]. In this webinar, our Bioanalysis Zone Rising Star Award winner (TBA) will introduce a systematic approach that allows efficient and consistent ligand binding based bioanalytical method development.
Webinar available to view on demand. This webinar talks about the benefit of incorporating microsampling techniques in bioanalytical assays, as well as the effort required to overcome the challenges.
Webinar available to view on demand. Accurate and precise biomarker measurement is critical to identifying diagnostic markers and druggable targets. Learn how quantitative mass spectrometry ensures proper biomarker measurement and characterization.
Webinar available on demand. Join our webinar to learn about the critical parameters related to the development of cell-based assays, the expected challenges and how binding assays could potentially be an acceptable replacement.
Webinar available to view on demand. In this panel discussion, we hear from key experts in the field about their research and expertise, how they overcome key challenges associated with the technologies they work with and what they envision for the future of biomarker research and validation.
Webinar available to view on demand. Selection and validation of biomarkers can be the difference between the success and failure of a pharmaceutical or biopharmaceutical drug development program.
Webinar available to view on demand. The application of differential mobility spectrometry to overcome selectivity and sensitivity challenges for both small and large molecule quantitation in bioanalysis.
Find out more about the latest news and developments in labs-on-chips in the investigation of gut inflammation and cellular responses in drug discovery in this round-up.
In this interview Alex Hawes (LGC; Cambridge, UK) discusses the topic of immunogenicity. She explains how she developed her first anti-drug antibody analytical method and the platforms LGC use in their immunogenicity sector.
Find out more about working with immunogenicity as well as what the future may hold for the field in this interview with Joyce Slusser (KCAS).